Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

Blood (2024) 144 (23): 2389–2401.

https://doi.org/10.1182/blood.2024024582

Published: 2024

Includes: Supplemental data

Journal Articles

Novel SRRM2-Targeted CAR-T Therapy Induces Rapid Remission in a Relapsed/Refractory Multiple Myeloma Patient

Zhitao Wang, Zhimai Gao, Fan Wu, Huiping Wang, Jinjing Guo, Yingwei Li, Zijian Li, Kathrin Gärtner, Lietao Li, Cong Li, Xue Liang, Hao Xiao, Zhimin Zhai

Blood (2024) 144 (Supplement 1): 7094.

https://doi.org/10.1182/blood-2024-201947

Published: 2024

Journal Articles

The Burden of Hematologic Malignancies in Southeast Asia from 1990 to 2021: Estimates from the Global Burden of Disease Study

Frances Dominique V. Ho, Edward Christopher Dee, Erin Jay G. Feliciano, Urvish Jain, Aryan Sekolar, Bhav Jain, Rod Carlo Columbres, Nishwant Swami, James Fan Wu

Blood (2024) 144 (Supplement 1): 7755.

https://doi.org/10.1182/blood-2024-202702

Published: 2024

Journal Articles

Evolution of Survival Disparities Among Adolescents and Young Adults with AML in the US

Erin Garbes Feliciano, Edward Christopher Dee, James Fan Wu, Juana Martinez, Angelica Singh, Nagma Shah, Urvish Jain

Blood (2024) 144 (Supplement 1): 529.

https://doi.org/10.1182/blood-2024-206581

Published: 2024

Journal Articles

Safety and Feasibility of Intrathecal Infusion of CD19 and/or CD22 CAR T Cells in r/r B-ALL Patients with CNSL or High-Risk CNS Relapse

Yibing Zhang, Jing PAN, Fan Wu, Zhuojun Ling, Kai Wang

Blood (2024) 144 (Supplement 1): 3466.

https://doi.org/10.1182/blood-2024-201376

Published: 2024

Journal Articles

Clinical Implications of CSF-Ctdna Positivity in Newly Diagnosed Diffuse Large B Cell Lymphoma in a Large Cohort

Jinhua Liang, Yi-fan Wu, Jun-heng Liang, Yue Li, Xin-Yu Zhang, Hao-Rui Shen, Jiazhu Wu, Liu qing Zhu, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 576.

https://doi.org/10.1182/blood-2024-194820

Published: 2024

Journal Articles

The Surface-Exposed Nuclear Speckle Protein SRRM2 Confers a Novel Target Molecule for the Immunotherapy of Acute Myeloid Leukemia

Wanqiu Zhang, Zhimai Gao, Kathrin Gärtner, Huiping Wang, Fan Wu, Jinjing Guo, Yingwei Li, Zijian Li, Lietao Li, Cong Li, Xue Liang, Hao Xiao, Zhimin Zhai

Blood (2024) 144 (Supplement 1): 7171.

https://doi.org/10.1182/blood-2024-201180

Published: 2024

Journal Articles

Inhibitor-Positive Hemophilia a Patients-Derived Humanized Mouse Models Revealed the Connection of PD-1/PD-L1 Interactions to Successful Immune Tolerance Induction (ITI) Therapy

Li-Fu Chen, Sheng-Chieh Chou, Yen-Ting Chang, I-Shing Yu, Yu-Chun Liao, Chien-Hung Liu, Shih-Fan Wu, Te-Hsien Liu, Kuei-Liang Chen, Cheng-Pu Sun, Ying-Hui Su, Chin-Yu Cheng, Bin-Bin Lin, Cheng-An Hsu, Mi-Hua Tao, Wen-Chien Chou, Shu-Wha Lin

Blood (2024) 144 (Supplement 1): 2572.

https://doi.org/10.1182/blood-2024-201182

Published: 2024

Journal Articles

Safety and Efficacy of Allogeneic NKG2D NKR-NK for Acute Myeloid Leukemia

Li Zhou, Haihao Shen, Fang Fang, Ming Zhang, Zuhong Hu, Congmiao Wu, Qianshan Tao, Yingwei Li, Fan Wu, Ying Pan, Zhitao Wang, Weihua Xiao, Zhimin Zhai

Blood (2024) 144 (Supplement 1): 7202.

https://doi.org/10.1182/blood-2024-201973

Published: 2024

Journal Articles

CD7 CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia: A Retrospective Study

Jing PAN, Liping Zhao, Fan Wu, Zhuojun Ling, Kai Wang

Blood (2024) 144 (Supplement 1): 964.

https://doi.org/10.1182/blood-2024-201362

Published: 2024

Journal Articles

The Epidemiology of Hematologic Malignancies in East Asia from 1990 to 2021: Estimates from the Global Burden of Disease Study

James Fan Wu, Frances Dominique V. Ho, Erin Jay G. Feliciano, Urvish Jain, Aryan Sekolar, Bhav Jain, Rod Carlo Columbres, Nishwant Swami, Edward Christopher Dee

Blood (2024) 144 (Supplement 1): 3725.

https://doi.org/10.1182/blood-2024-194608

Published: 2024

Journal Articles

Vincristine Overcomes Cytarabine Resistance in Acute Myeloid Leukemia By Suppression of ARHGAP18-Mediated Cellular Senescence

Xiyang Ren, Haotian Yan, Mei Zhou, Fan Wu, Qing Zhang, Yangyang Ding, Qian Li, Huiping Wang, Caixian Xu, Jiyu Wang, Cong Li, Wanqiu Zhang, Linlin Liu, Ruotong Chen, Yi Dong, Wenjie Dai, Zhimin Zhai, Qianshan Tao

Blood (2024) 144 (Supplement 1): 2754.

https://doi.org/10.1182/blood-2024-205440

Published: 2024

Journal Articles

Cross-Cohort Correlative Analysis of Clinically High-Risk Patients (pts) Treated with Idecabtagene Vicleucel (ide-cel) in KarMMa-2: Association between Progression-Free Survival (PFS) and Tumor Burden and Immune Status at Apheresis

Debashree Basudhar, Dante Descalzi-Montoya, Hao Tang, Minshi Wang, Fan Wu, P. Leif Bergsagel, Xavier Leleu, Daniela Hosseyni, Maria Chaudhry, Nathan Martin, Ethan G. Thompson

Blood (2024) 144 (Supplement 1): 3382.

https://doi.org/10.1182/blood-2024-198740

Published: 2024

Journal Articles

Clinical Implications of Ctdna-Based Minimal Residual Disease Detection in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Jinhua Liang, Yi-fan Wu, Hao-Rui Shen, Jiazhu Wu, Jun-heng Liang, Liu-Qing Zhu, Hua Yin, Yue Li, Li Wang, Jianyong Li, Xu Wei

Blood (2024) 144 (Supplement 1): 1709.

https://doi.org/10.1182/blood-2024-201220

Published: 2024

Journal Articles

Idecabtagene Vicleucel (Ide-cel) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) with an Inadequate Response to Front-Line Autologous Stem Cell Transplantation (ASCT): KarMMa-2 Cohort 2c Extended Follow-up

Blood (2024) 144 (Supplement 1): 3388.

https://doi.org/10.1182/blood-2024-200829

Published: 2024

Journal Articles

Elevated Circulating CD10¯ G-MDSC-like Neutrophils of Acute Myeloid Leukemia Patients in Complete Remission Status Are Correlated with Relapse and Poor Prognosis

Xunyi Jiao, Xue Liang, Jinli Zhu, Ji Zhou, Meng Xiao, Hao Xiao, Qianshan Tao, Yingwei Li, Fan Wu, Huiping Wang, Zhimin Zhai

Blood (2024) 144 (Supplement 1): 4301.

https://doi.org/10.1182/blood-2024-209946

Published: 2024

Journal Articles

A Mediator Switch Tunes Transcription Pausing to Drive Erythropoiesis

Hsiang-Ying Lee, Shicong Zhu, Xiaoting Zhang, Man Li, Xinying Zhao, Na Li, Sera Xie, Qiuyu Yue, Yunfeng Li, Dong Li, Fan Wu, Zile Zhang, Ziqi Feng, Yuelin Deng, Qi Hu, Xingyun Yao, Xiaofei Gao

Blood (2023) 142 (Supplement 1): 10.

https://doi.org/10.1182/blood-2023-189195

Published: 2023

Journal Articles

Clinical Implications of CSF-Ctdna in CNS Involvement of Newly Diagnosed Diffuse Large B Cell Lymphoma: An Improvement of Diagnosis, Treatment and Evaluation

Jinhua Liang, Yi-fan Wu, Hao-Rui Shen, Yue Li, Jun-heng Liang, Xin-Yu Zhang, Sibusiso Luthuli, Jiazhu Wu, Liu qing Zhu, Hua Yin, Li Wang, Jianyong Li, Xu Wei

Blood (2023) 142 (Supplement 1): 188.

https://doi.org/10.1182/blood-2023-181666

Published: 2023

Journal Articles

MED16 Negatively Regulates Erythropoiesis and Myelopoiesis through Modulation of Chromatin Accessibility

Sera Xie, Fan Wu, Xinying Zhao, Qiuyu Yue, Shicong Zhu, Ling-Hui Yan, Yuan Zhou, Tong Xing, Qi Hu, Dong Li, Jin-Song Jia, Yuan Kong, Xiao-Jun Huang, Xiaofei Gao, Hsiang-Ying Lee

Blood (2023) 142 (Supplement 1): 2673.

https://doi.org/10.1182/blood-2023-189650

Published: 2023

Journal Articles

CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study

Liping Zhao, Qi Zhou, Chen Chen, Zhuojun Ling, Kai Wang, Fan Wu, Jinlong Xu, Jiajia Duan, Zelin Wang, Quangang Wang, Jing PAN

Blood (2023) 142 (Supplement 1): 3480.

https://doi.org/10.1182/blood-2023-182538

Published: 2023

NARROW

Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

Novel SRRM2-Targeted CAR-T Therapy Induces Rapid Remission in a Relapsed/Refractory Multiple Myeloma Patient

The Burden of Hematologic Malignancies in Southeast Asia from 1990 to 2021: Estimates from the Global Burden of Disease Study

Evolution of Survival Disparities Among Adolescents and Young Adults with AML in the US

Safety and Feasibility of Intrathecal Infusion of CD19 and/or CD22 CAR T Cells in r/r B-ALL Patients with CNSL or High-Risk CNS Relapse

Clinical Implications of CSF-Ctdna Positivity in Newly Diagnosed Diffuse Large B Cell Lymphoma in a Large Cohort

The Surface-Exposed Nuclear Speckle Protein SRRM2 Confers a Novel Target Molecule for the Immunotherapy of Acute Myeloid Leukemia

Inhibitor-Positive Hemophilia a Patients-Derived Humanized Mouse Models Revealed the Connection of PD-1/PD-L1 Interactions to Successful Immune Tolerance Induction (ITI) Therapy

Safety and Efficacy of Allogeneic NKG2D NKR-NK for Acute Myeloid Leukemia

CD7 CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia: A Retrospective Study

The Epidemiology of Hematologic Malignancies in East Asia from 1990 to 2021: Estimates from the Global Burden of Disease Study

Vincristine Overcomes Cytarabine Resistance in Acute Myeloid Leukemia By Suppression of ARHGAP18-Mediated Cellular Senescence

Cross-Cohort Correlative Analysis of Clinically High-Risk Patients (pts) Treated with Idecabtagene Vicleucel (ide-cel) in KarMMa-2: Association between Progression-Free Survival (PFS) and Tumor Burden and Immune Status at Apheresis

Clinical Implications of Ctdna-Based Minimal Residual Disease Detection in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Idecabtagene Vicleucel (Ide-cel) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) with an Inadequate Response to Front-Line Autologous Stem Cell Transplantation (ASCT): KarMMa-2 Cohort 2c Extended Follow-up

Elevated Circulating CD10¯ G-MDSC-like Neutrophils of Acute Myeloid Leukemia Patients in Complete Remission Status Are Correlated with Relapse and Poor Prognosis

A Mediator Switch Tunes Transcription Pausing to Drive Erythropoiesis

Clinical Implications of CSF-Ctdna in CNS Involvement of Newly Diagnosed Diffuse Large B Cell Lymphoma: An Improvement of Diagnosis, Treatment and Evaluation

MED16 Negatively Regulates Erythropoiesis and Myelopoiesis through Modulation of Chromatin Accessibility

CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only